Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004872043 | SCV005518327 | uncertain significance | not specified | 2024-10-04 | criteria provided, single submitter | clinical testing | The c.2117G>A (p.R706Q) alteration is located in exon 13 (coding exon 12) of the TDRD5 gene. This alteration results from a G to A substitution at nucleotide position 2117, causing the arginine (R) at amino acid position 706 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |